Literature DB >> 24339157

Youth and environmental enrichment generate serum exosomes containing miR-219 that promote CNS myelination.

Aya D Pusic1, Richard P Kraig.   

Abstract

Although commonly considered a disease of white matter, gray matter demyelination is increasingly recognized as an important component of multiple sclerosis (MS) pathogenesis, particularly in the secondary progressive disease phase. Extent of damage to gray matter is strongly correlated to decline in memory and cognitive dysfunction in MS patients. Aging likewise occurs with cognitive decline from myelin loss, and age-associated failure to remyelinate significantly contributes to MS progression. However, recent evidence demonstrates that parabiotic exposure of aged animals to a youthful systemic milieu can promote oligodendrocyte precursor cell (OPC) differentiation and improve remyelination. In the current study, we focus on this potential for stimulating remyelination, and show it involves serum exosomes that increase OPCs and their differentiation into mature myelin-producing cells-both under control conditions and after acute demyelination. Environmental enrichment (EE) of aging animals produced exosomes that mimicked this promyelinating effect. Additionally, stimulating OPC differentiation via exosomes derived from environmentally enriched animals is unlikely to deplete progenitors, as EE itself promotes proliferation of neural stem cells. We found that both young and EE serum-derived exosomes were enriched in miR-219, which is necessary and sufficient for production of myelinating oligodendrocytes by reducing the expression of inhibitory regulators of differentiation. Accordingly, protein transcript levels of these miR-219 target mRNAs decreased following exosome application to slice cultures. Finally, nasal administration of exosomes to aging rats also enhanced myelination. Thus, peripheral circulating cells in young or environmentally enriched animals produce exosomes that may be a useful therapy for remyelination.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  aging; hippocampal slice culture; multiple sclerosis; neuroimmune; remyelination

Mesh:

Substances:

Year:  2013        PMID: 24339157      PMCID: PMC4096126          DOI: 10.1002/glia.22606

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  71 in total

1.  Lysolecithin induces demyelination in vitro in a cerebellar slice culture system.

Authors:  Eric Birgbauer; Tadimeti S Rao; Michael Webb
Journal:  J Neurosci Res       Date:  2004-10-15       Impact factor: 4.164

2.  Intranasal administration of insulin-like growth factor-I bypasses the blood-brain barrier and protects against focal cerebral ischemic damage.

Authors:  X F Liu; J R Fawcett; R G Thorne; T A DeFor; W H Frey
Journal:  J Neurol Sci       Date:  2001-06-15       Impact factor: 3.181

3.  NS21: re-defined and modified supplement B27 for neuronal cultures.

Authors:  Yucui Chen; Beth Stevens; Jufang Chang; Jeffrey Milbrandt; Ben A Barres; Johannes W Hell
Journal:  J Neurosci Methods       Date:  2008-04-01       Impact factor: 2.390

4.  Cell-cell interactions during the migration of myelin-forming cells transplanted in the demyelinated spinal cord.

Authors:  A Baron-Van Evercooren; V Avellana-Adalid; A Ben Younes-Chennoufi; A Gansmuller; B Nait-Oumesmar; L Vignais
Journal:  Glia       Date:  1996-02       Impact factor: 7.452

5.  Resting microglial cells in vitro: analysis of morphology and adhesion molecule expression in organotypic hippocampal slice cultures.

Authors:  N P Hailer; J D Jarhult; R Nitsch
Journal:  Glia       Date:  1996-12       Impact factor: 7.452

6.  Crucial role of the local micro-environment in fate decision of neonatal rat NG2 progenitors.

Authors:  J Sypecka; A Sarnowska; K Domanska-Janik
Journal:  Cell Prolif       Date:  2009-07-09       Impact factor: 6.831

Review 7.  Taking ageing into account in remyelination-based therapies for multiple sclerosis.

Authors:  Julia M Rist; Robin J M Franklin
Journal:  J Neurol Sci       Date:  2008-06-09       Impact factor: 3.181

Review 8.  Remyelination in multiple sclerosis.

Authors:  Wolfgang Brück; Tanja Kuhlmann; Christine Stadelmann
Journal:  J Neurol Sci       Date:  2003-02-15       Impact factor: 3.181

9.  What is the optimal value of the g-ratio for myelinated fibers in the rat CNS? A theoretical approach.

Authors:  Taylor Chomiak; Bin Hu
Journal:  PLoS One       Date:  2009-11-13       Impact factor: 3.240

10.  Dicer ablation in oligodendrocytes provokes neuronal impairment in mice.

Authors:  Daesung Shin; Ji-Yeon Shin; Michael T McManus; Louis J Ptácek; Ying-Hui Fu
Journal:  Ann Neurol       Date:  2009-12       Impact factor: 10.422

View more
  77 in total

Review 1.  Glial Regulation of the Neuronal Connectome through Local and Long-Distant Communication.

Authors:  R Douglas Fields; Dong Ho Woo; Peter J Basser
Journal:  Neuron       Date:  2015-04-22       Impact factor: 17.173

2.  Biological properties of extracellular vesicles and their physiological functions.

Authors:  María Yáñez-Mó; Pia R-M Siljander; Zoraida Andreu; Apolonija Bedina Zavec; Francesc E Borràs; Edit I Buzas; Krisztina Buzas; Enriqueta Casal; Francesco Cappello; Joana Carvalho; Eva Colás; Anabela Cordeiro-da Silva; Stefano Fais; Juan M Falcon-Perez; Irene M Ghobrial; Bernd Giebel; Mario Gimona; Michael Graner; Ihsan Gursel; Mayda Gursel; Niels H H Heegaard; An Hendrix; Peter Kierulf; Katsutoshi Kokubun; Maja Kosanovic; Veronika Kralj-Iglic; Eva-Maria Krämer-Albers; Saara Laitinen; Cecilia Lässer; Thomas Lener; Erzsébet Ligeti; Aija Linē; Georg Lipps; Alicia Llorente; Jan Lötvall; Mateja Manček-Keber; Antonio Marcilla; Maria Mittelbrunn; Irina Nazarenko; Esther N M Nolte-'t Hoen; Tuula A Nyman; Lorraine O'Driscoll; Mireia Olivan; Carla Oliveira; Éva Pállinger; Hernando A Del Portillo; Jaume Reventós; Marina Rigau; Eva Rohde; Marei Sammar; Francisco Sánchez-Madrid; N Santarém; Katharina Schallmoser; Marie Stampe Ostenfeld; Willem Stoorvogel; Roman Stukelj; Susanne G Van der Grein; M Helena Vasconcelos; Marca H M Wauben; Olivier De Wever
Journal:  J Extracell Vesicles       Date:  2015-05-14

Review 3.  Systemic milieu and age-related deterioration.

Authors:  Hongxia Zhang; Ryan Cherian; Kunlin Jin
Journal:  Geroscience       Date:  2019-05-31       Impact factor: 7.713

4.  Enriched environment modulates behavior, myelination and augments molecules governing the plasticity in the forebrain region of rats exposed to chronic immobilization stress.

Authors:  Gangadharan Thamizhoviya; Arambakkam Janardhanam Vanisree
Journal:  Metab Brain Dis       Date:  2019-01-02       Impact factor: 3.584

Review 5.  Neuroimmune Crosstalk through Extracellular Vesicles in Health and Disease.

Authors:  Jean-Christophe Delpech; Shawn Herron; Mina B Botros; Tsuneya Ikezu
Journal:  Trends Neurosci       Date:  2019-03-26       Impact factor: 13.837

Review 6.  Extracellular Vesicles for Research on Psychiatric Disorders.

Authors:  Shin-Ichi Kano; Eisuke Dohi; Indigo V L Rose
Journal:  Schizophr Bull       Date:  2019-01-01       Impact factor: 9.306

7.  Extracellular vesicles as modulators of cell-to-cell communication in the healthy and diseased brain.

Authors:  D M Pegtel; L Peferoen; S Amor
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2014-09-26       Impact factor: 6.237

8.  What are exosomes and how can they be used in multiple sclerosis therapy?

Authors:  Aya D Pusic; Kae M Pusic; Richard P Kraig
Journal:  Expert Rev Neurother       Date:  2014-02-19       Impact factor: 4.618

Review 9.  Exosomal miRNAs in central nervous system diseases: biomarkers, pathological mediators, protective factors and therapeutic agents.

Authors:  Xiaohuan Xia; Yi Wang; Yunlong Huang; Han Zhang; Hongfang Lu; Jialin C Zheng
Journal:  Prog Neurobiol       Date:  2019-09-19       Impact factor: 11.685

10.  Quantum dot-mediated delivery of siRNA to inhibit sphingomyelinase activities in brain-derived cells.

Authors:  Ted Getz; Jingdong Qin; Igor L Medintz; James B Delehanty; Kimihiro Susumu; Philip E Dawson; Glyn Dawson
Journal:  J Neurochem       Date:  2016-10-14       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.